These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18458264)
1. Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace? Hernandez AF; Harrington RA CMAJ; 2008 May; 178(10):1316-9. PubMed ID: 18458264 [No Abstract] [Full Text] [Related]
2. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. Pilote L; Abrahamowicz M; Eisenberg M; Humphries K; Behlouli H; Tu JV CMAJ; 2008 May; 178(10):1303-11. PubMed ID: 18458262 [TBL] [Abstract][Full Text] [Related]
3. ACE inhibitors in heart failure: effect on mode of death. Kübler W Eur Heart J; 1997 Jan; 18(1):3-4. PubMed ID: 9049504 [No Abstract] [Full Text] [Related]
4. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats. Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers]. Costantino S; Millozzi F; Scarlata S Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526 [No Abstract] [Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
8. [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction]. Kardiologiia; 2008; 48(11):64-8. PubMed ID: 19076083 [TBL] [Abstract][Full Text] [Related]
9. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Dinicolantonio JJ; Lavie CJ; O'Keefe JH Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903 [TBL] [Abstract][Full Text] [Related]
10. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. Garg R; Yusuf S JAMA; 1995 May; 273(18):1450-6. PubMed ID: 7654275 [TBL] [Abstract][Full Text] [Related]
11. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Teo K; Yusuf S; Sleight P; Anderson C; Mookadam F; Ramos B; Hilbrich L; Pogue J; Schumacher H; Am Heart J; 2004 Jul; 148(1):52-61. PubMed ID: 15215792 [TBL] [Abstract][Full Text] [Related]
12. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors? Shah AD; Arora RR Clin Cardiol; 2005 Dec; 28(12):551-5. PubMed ID: 16405197 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF; Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827 [TBL] [Abstract][Full Text] [Related]
14. Do all patients with coronary artery disease benefit from angiotensin converting enzyme inhibitors? Shah AD; Arora RR J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):281-3. PubMed ID: 16382264 [TBL] [Abstract][Full Text] [Related]
15. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors? Francis GS; Gassler JP Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844 [No Abstract] [Full Text] [Related]